India
· Delayed Price · Currency is INR Syngene International Company Description
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services.
It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services.
In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization.
It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies.
The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India.
Syngene International Limited is a subsidiary of Biocon Limited.
| Country | India |
| Founded | 1993 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 6,510 |
| CEO | Peter James Bains |
Contact Details
Address: Biocon SEZ, Biocon Park Bengaluru, Karnataka 560099 India | |
| Phone | 91 80 6891 8000 |
| Website | syngeneintl.com |
Stock Details
| Ticker Symbol | SYNGENE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE398R01022 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Peter James Jonathan Bains | Chief Executive Officer and MD |
| Deepak Jain | Chief Financial Officer |
| Dr. Jayashree Aiyar Ph.D. | Chief Scientific Officer |
| Krishnan G | Head of Investor Relations |
| Sandeep Nair | Head of Corporate Communications |
| Andrew Webster | Chief Human Resources Officer |
| Dr. Dhananjay Patankar | Head of Pharmaceutical and Biopharmaceutical Development |
| Purushottam Shashikant Singnurkar | Head of Formulations Development |
| Ajit Manocha | Head of IT |
| Dr. Chetan Prakash Tamhankar | Head of Clinical Development and Stability Studies |